Answer
Hydrocortisone in Softacort eye drops releases and induces synthesis of lipocortin, a phospholipase A2 (PLA2) inhibitor, blocking the arachidonate cascade and formation of inflammatory factors such as prostaglandins, thromboxanes and leukotrienes.
Sources for this answer
- SOFTACORT 3.35 mg/ml eye drops, solution in single-dose containerThea Pharmaceuticals Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked